Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Creams: SOP for Particle Size Analysis in Cream Emulsions – V 2.0

Posted on By

Creams: SOP for Particle Size Analysis in Cream Emulsions – V 2.0

Standard Operating Procedure for Particle Size Analysis in Cream Emulsions

Department Creams
SOP No. SOP/CRM/140/2025
Supersedes SOP/CRM/140/2022
Page No. Page 1 of 5
Issue Date 21/01/2026
Effective Date 26/01/2026
Review Date 21/01/2027

1. Purpose

The purpose of this SOP is to define the procedure for performing particle size analysis of cream emulsions. Particle size plays a critical role in the stability, texture, and performance of cream products. This test ensures that the particle size distribution is within the desired range to meet the product specifications and optimize its quality.

2. Scope

This SOP applies to all cream emulsions produced at the facility. It covers the process for measuring and analyzing the particle size of emulsions both during the formulation process and in the finished cream products.

3. Responsibilities

  • Production Team: Responsible for ensuring that the cream emulsions are correctly prepared and that the desired particle size specifications are achieved during formulation.
  • Quality Control (QC) Team: Responsible for conducting particle size analysis and ensuring that the results meet the specified requirements.
  • Quality Assurance (QA) Team: Responsible for reviewing and approving the results of the particle size analysis to ensure compliance with internal specifications
and regulatory standards.

4. Accountability

The QC Manager is accountable for ensuring that particle size analysis is performed in accordance with this SOP. The Production Supervisor is responsible for providing the representative samples for testing. The QA Manager ensures that the test results are reviewed and approved in compliance with GMP and regulatory standards.

5. Procedure

5.1 Pre-Test Preparation

  1. Ensure that the necessary equipment for particle size analysis is available, including a laser diffraction analyzer, particle size analyzer, or any other suitable instruments for measurement.
  2. Calibrate the particle size analyzer according to the manufacturer’s instructions to ensure accurate measurements.
  3. Review the batch record to confirm the formulation details, including the type of emulsifier and stabilizer used, and the intended particle size distribution for the cream emulsion.

5.2 Sample Collection

  1. Collect a representative sample of the cream emulsion from the finished batch. The sample should be homogenous and free from contamination.
  2. Label the sample with the batch number, sample ID, sampling date, and other relevant details to ensure traceability during testing.
  3. Ensure that the sample is collected from sealed containers to maintain the integrity of the emulsion and prevent contamination during testing.

5.3 Particle Size Analysis Procedure

  1. Place the sample into the particle size analyzer. If necessary, dilute the sample with an appropriate solvent to achieve optimal concentration for analysis.
  2. Set the analyzer to the appropriate particle size measurement mode (e.g., laser diffraction, dynamic light scattering) and initiate the measurement procedure.
  3. Conduct at least three measurements for each sample to ensure consistency. The measurements should be performed at different time intervals if required (e.g., initial, after emulsification, and after storage).
  4. Record the particle size distribution, including the mean particle size, median size, and span (a measure of the width of the size distribution) in the Particle Size Analysis Log (Annexure-1).

5.4 Interpretation of Results

  1. Review the particle size distribution results, ensuring that the particle size is within the specified range for the cream formulation. Typically, emulsions with smaller particle sizes (less than 10 microns) are preferred for smooth texture and stability.
  2. Acceptable particle size distribution is defined by the specification for the specific formulation. If the particle size is outside the acceptable range, mark the result as “Fail.”
  3. If the test fails, investigate potential causes such as improper emulsification, insufficient mixing, or incorrect formulation components, and perform corrective actions as necessary.
  4. Record all deviations, investigations, and corrective actions in the Particle Size Analysis Log (Annexure-1) and submit the results for further review.

5.5 Post-Test Activities

  1. Record all test results, including batch number, sample ID, particle size distribution, and any corrective actions taken, in the Particle Size Analysis Log (Annexure-1).
  2. If the particle size is found to be out of specification, initiate corrective actions such as reprocessing the emulsion or modifying the formulation, and re-test after corrective actions.
  3. Submit the test results for review and approval by the QA team to ensure compliance with internal and regulatory standards.

5.6 Documentation and Record-Keeping

  1. Ensure that all particle size analysis records are complete, accurate, and securely stored. This includes the Particle Size Analysis Log (Annexure-1) and the Deviation Log (Annexure-2) for failed tests.
  2. Retain all records for a minimum of two years or as required by regulatory guidelines.
  3. Ensure that records are reviewed and approved by the Quality Assurance team to verify compliance with GMP standards and regulatory requirements.

6. Abbreviations

  • GMP: Good Manufacturing Practices
  • QC: Quality Control
  • QA: Quality Assurance
  • PPE: Personal Protective Equipment
  • μm: Micrometer (used for particle size)

7. Documents

  1. Annexure-1: Particle Size Analysis Log
  2. Annexure-2: Deviation Log

8. References

  • Good Manufacturing Practices (GMP) Guidelines – 21 CFR Part 211
  • ISO 13320 – Particle Size Analysis – Laser Diffraction Methods
  • International Pharmaceutical Excipients Council (IPEC) Guidelines on Emulsion Formulations

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Particle Size Analysis Log

Batch Number Sample ID Test Date Particle Size (μm) Operator
12345 S-001 21/01/2026 5.2 John Doe

Annexure-2: Deviation Log

Deviation Date Batch Number Deviation Description Corrective Action Taken Operator
21/01/2026 12345 Particle size out of specification Reformulated and re-tested Jane Smith

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/03/2024 1.0 Initial Version New SOP Creation QA Head
01/03/2025 2.0 Format Revision and Updates Standardization of Document QA Head
See also  Creams: SOP for Odor Stability Testing in Cream Formulations - V 2.0
Creams V 2.0 Tags:Batch record documentation for creams, Change control procedures for cream manufacturing, Cleaning and sanitization SOPs in creams production, Complaint handling SOPs in creams production, Continuous improvement SOPs for cream manufacturing, Cream manufacturing process guidelines, Creams production documentation practices, Deviation handling SOPs in creams production, Employee training SOPs in creams manufacturing, Environmental monitoring SOPs in creams manufacturing, Equipment calibration SOPs for cream manufacturing, GMP compliance in creams production, Internal audit procedures in creams production, Packaging and labeling SOPs for creams, Pharmaceutical SOPs, Product quality review procedures for creams, Product release criteria SOPs for creams, Quality control SOPs for creams, ream manufacturing SOP, Regulatory requirements for cream production SOPs, Risk management SOPs in creams manufacturing, Stability testing SOPs for cream products, Standard operating procedures for skincare products, Supplier qualification SOPs for cream ingredients, Validation protocols for cream production processes

Post navigation

Previous Post: Biosimilars: SOP for Harmonizing MCB/WCB Data with QA System – V 2.0
Next Post: BA-BE Studies: SOP for Securing and Tracking of Biological Waste – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version